Related Experiment Video

Updated: Aug 16, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

Ultrastructural effects of acute organophosphate poisoning on rat kidney

Salim Satar1, Deniz Satar, Ufuk Ozgu Mete

  • 1Department of Emergency Medicine, School of Medicine, Cukurova University, Balcali, Adana 01330, Turkey. ssatar@cu.edu.tr

Renal Failure
|September 13, 2005
PubMed

Insights

Acute methamidophos poisoning in rats, even at lethal doses, did not cause kidney ultrastructural changes. Antidotal treatment with atropine and pralidoxime (2-PAM) also showed no kidney damage in this organophosphate study.

Area of Science:

  • Toxicology
  • Nephrology
  • Histopathology

Background:

  • Organophosphate compounds, like methamidophos, are widely used pesticides.
  • Exposure to organophosphates can lead to acute poisoning with potential systemic effects.
  • Understanding the impact of these compounds on vital organs, such as the kidney, is crucial.

Purpose of the Study:

  • To investigate the ultrastructural effects of acute methamidophos poisoning on rat kidneys.
  • To evaluate the impact of antidotal treatment (atropine and 2-PAM) on kidney histology following methamidophos exposure.
  • To determine if methamidophos exposure or its treatment causes histopathological changes in the kidney.

Main Methods:

  • Male Wistar albino rats were divided into four groups: methamidophos exposure, saline control, methamidophos with antidotes, and saline control for antidotes.
  • Organophosphate toxicity was induced using the LD50 dose of methamidophos.
  • Kidney tissues were examined using electron microscopy to assess ultrastructural changes.

Main Results:

  • No ultrastructural alterations were observed in the kidneys of rats acutely poisoned with methamidophos.
  • Kidney tissues from rats treated with atropine and 2-PAM after methamidophos exposure also showed no significant ultrastructural changes.
  • The study found no histopathological evidence of kidney damage associated with acute methamidophos poisoning or its antidotal treatment in this rat model.

Conclusions:

  • Acute methamidophos poisoning, at the LD50 dose, does not induce detectable ultrastructural damage in rat kidneys.
  • Antidotal treatment with atropine and 2-PAM does not appear to cause kidney histopathological changes in the context of methamidophos poisoning.
  • Further studies with different organophosphate compounds and varying dosages may be necessary to fully elucidate their renal effects.

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...